| Financial Year |
March 31 2023 |
| Monetary Funds |
427,446,480.23 |
| Held-for-trading Financial Assets |
1,659,530,775.79 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,499,594,806.48 |
| Advances to Suppliers |
21,680,510.61 |
| Other Receivables |
3,754,439.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
321,355,281.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
130,000,000.00 |
| Other Current Assets |
1,870.33 |
| Total Current Assets |
4,063,364,164.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,260,265,910.39 |
| Under-construction Projects |
3,297,915.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
236,944.89 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,615,781.53 |
| R&D expenses |
24,276,738.96 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,001,574.02 |
| Deferred Income Tax Assets |
198,842,963.88 |
| Other Non-Current Assets |
1,528,385,209.76 |
| Sub-Total of Non-Current Assets |
3,038,923,038.65 |
| Total Assets |
7,102,287,203.11 |
| Short-Term Loans |
300,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,072,110.00 |
| Accounts Payable |
140,879,121.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
-- |
| Taxes Payable |
8,258,060.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
998,578,823.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
100,912.63 |
| Sub-Total of Current Liabilities |
1,461,256,579.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,686,916.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,284,698.96 |
| Total Liabilities |
1,504,541,278.82 |
| Paid-In Capital(Or Share Stock) |
400,010,000.00 |
| Capital Surplus |
3,095,833,599.42 |
| Surplus Reserve |
200,005,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,901,897,324.87 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,597,745,924.29 |
| Owner's Equity（Stockholder's Equity） |
5,597,745,924.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,102,287,203.11 |
